Position in TXG
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$4,167,251
+$1,726,396 QoQ
Shares Held
108,692
-5.5% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in TXG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $220,215,684 across 64 Medical Devices names. TXG ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
609,854 | $55,338,151 | |
| 2 | SYK |
Stryker Corp
|
142,133 | $44,749,153 | |
| 3 | MDT |
Medtronic plc
|
504,928 | $39,500,517 | |
| 4 | EW |
Edwards Lifesciences Corp
|
279,851 | $25,315,321 | |
| 5 | BSX |
Boston Scientific Corp
|
206,605 | $8,817,901 | |
| 6 | DXCM |
Dexcom Inc
|
68,879 | $4,639,000 | |
| 7 | PODD |
Insulet Corp
|
27,766 | $4,227,373 | |
| 8 | STE |
STERIS plc
|
19,913 | $4,193,080 |
All Filings in TXG
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,167,251 | 108,692 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $2,440,855 | 114,972 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,358,068 | 83,266 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $541,574 | 46,328 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $278,452 | 24,046 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||